venBio Select Advisor »

Kyverna Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 475k 24.84

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common

View all positions for venBio Select Advisor

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Novo A/S
BlackRock
BlackRock
Vanguard Group
Franklin Resources
Deerfield Management Company
Insight Holdings
T. Rowe Price Associates
Mbb Public Markets I
EcoR1 Capital
Geode Capital Management

View all funds holding Kyverna Therapeutics